BridgeBio Pharma, Inc. - Common Stock — Cash Flow (NASDAQ:BBIO) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -399.71 M-497.93 M-419.49 M-527.72 M-520.73 M-445.91 M -443.95 M Cash from investing activities -52.99 M-200.83 M453.15 M54.03 M60.78 M-24.49 M -65.63 M Cash from financing activities 447.19 M736.45 M-13.13 M451.54 M748.46 M359.29 M 848.86 M Free cash flow -399.71 M-497.93 M-419.49 M-527.72 M-520.73 M-445.91 M -443.95 M

News

BioMarin's Voxzogo Meets Goal in Late-Stage Study for Hypochondroplasia

BridgeBio Pharma, Inc. (BBIO) Presents at Bank of America Global Healthcare Conference 2026 Transcript

BridgeBio Pharma, Inc. (BBIO) Q1 2026 Earnings Call Transcript

BridgeBio Pharma (BBIO) Reports Q1 Loss, Tops Revenue Estimates

Gartner Gears Up to Report Q1 Earnings: What's in the Offing?

IQVIA Set to Report Q1 Earnings: Here's What You Should Know

Alnylam Surges After Its Pfizer-Rivaling Blockbuster Jumps Nearly 200%

Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy?

Will BridgeBio Pharma (BBIO) Report Negative Q1 Earnings? What You Should Know

3 Best Stocks to Buy This Week, According to Analysts – April 26-May 1 - TipRanks.com

Four Biotech Stocks Near Buy Points As Earnings Season Kicks In

TechnipFMC Defies Market, Hits Record High, Leads 16 Top Performers To IBD Best Stock Lists